L-Lizina Colagenaza
L-Lizina inhiba colagenaza
L-Lizina in tratamentul de migrena
| L-Lizina un produs natural foarte efectiv in blocarea de colagenaza |
 |
| L-Lizina inhiba colagenaza la diverse boli ca: |
 |
Cancer
Ateroscleroza
Infectii virale ca:
- Gripa aviara,
- Herpes simplex,
- SIDA
Infectii bacteriene la:
- Plamini,
- Urechea interioara,
- Infectie de vezica urinara Inflamatii cronice:
- Ulcer,
- Inflamatii intestinale,
- Colita,
- Artrita,
- Boli reumatologice
Boli alergice
- Angioedemul,
- Urticarie,
- Neurodermita,
- Astma alergica,
- Rinita alergica,
- Conjunctivita alergica,
|
| L-Lizina inhiba colagenaza,
favorizeaza
sistemul imunitar |
 |
| L-Lizina inhibitor de colagenaza |
 |
- Liproproteina(apoa) are efect de lipire (Adeziune) de
peretii vasculari, a moleculei LDL (Low Density Lipoprotein) a depunerilor
de molecule
de Calciu si molecule de Zahar (glucoza).
| Placa de aterom cu
tromb |
 |
Cardiopatia ischemica poate fi produsa de cauze organice
cum ar fi:
Leziuni in peretii vasculari datorita oxidatiei din insuficienta a antioxidantilor
pentru reducerea radicalilor liberi, Coenzima Q10 este un antioxidant puternic.
- Din lipsa cronica de Vitamina C peretii vasculari primesc
leziuni iar efectele de reparatie a organizmului compenseaza necontrolat
cresterea cu celule musculare
Depunerilor cu Lipoproteina(a) = apoa in placa aterosclerotica.
1 L-Lizina reduce ateroscleroza prin modificarea de lipoproteina(a) = apoa.
2 L-Lizina cu succes in terapia infectiei recurenta de herpes simplex
3 L-Lizina cu succes in tratamentul si profilaxia infectiei recurente de herpes
simplex
4 L-Lizina in tratamentul de migrena, studiu randomizat dublu-orb placebo controlat.
5 Evidenta
imunologica de acumulare a Lipoproteina (apoa) in leziunea aterosclerotica
| L-Lizina inhiba colagenaza care favorizeaza avansarea de ateroscleroza |
 |
6. Rolul
de lipoproteina apoa in patogeneza anginei pectorale
| Rolul de
lipoproteina apoa in patogeneza anginei pectorale |
 |
L-Lizina are activitate de teflon pentru a inpiedica depunerea pe
peretele vascular de Lipoproteina (apoa)
7 L-Lizina
amelioreaza angina pectorala
8 L-Lizina indicat in terapia de herpes simplex, studiu multicentru
9 L-Lizina ca agent profilactic in terapia infectiei de herpes genital
10 L-Lizina in
tratamentul de profilaxa a osteoporozei
Structura normala de masa osoasa
|
Osteoporoza
|
La osteoporoza se subtiaza structura masei
osoase
|
|
|
|
|
11 L-Lizina
si Calciu in metabolismul uman, la osteoporoza
| L-Lizina inhiba colagenaza
in inflamatia articulara de artrita |
 |
12 Lizina
cu rol metabolic
13 Relatia
L-Lizina mai mica fata de L-Arginina, influenteaza metabolismul colesterolului
| Bibliografie-Referinte: |
 |
| Informatii din bibliografia electronica la tema: Nutritie si sanatate |
1 Boonmark NW, Lou XJ,
Yang ZJ, Schwartz K, Zhang JL, Rubin EM, Lawn RM. Modification
of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic
mice. Falk Cardiovascular Research Center, Stanford University School of
Medicine, Stanford, California 94305-5246, USA.J Clin Invest. 1997 Aug
1;100(3):558-64.
2 Griffith RS, Walsh DE, Myrmel KH, Thompson
RW, Behforooz A. Success
of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment
and prophylaxis. Department of Medicine, Indiana University School of Medicine,
Indianapolis. Dermatologica.
1987;175(4):183-90.
-Griffith RS, De Long DC,
Nelson JD. Relation of L-arginine—lysine antagonism to herpes simplex
growth in tissue culture. Chemotherapy. 1981; 27:209-213.
-
McCune MA, Perry HO, Muller SA, O'Fallon WM. Treatment
of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis.
1984 Oct;34(4):366-73.
3 Di Giovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes
simplex
infection. Treatment and prophylaxis. Arch Dermatol. 1984 Jan;120(1):48-51.
4 Krymchantowski AV, Barbosa JS, Cheim C, Alves LA. Oral
lysine clonixinate in the acute treatment of migraine: a double-blind placebo-controlled
study. Headache Center of Rio, Rio de Janeiro, Brazil. Arq Neuropsiquiatr.
2001 Mar;59(1):46-9.
5 Rath M, Pauling L. Immunological
evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion
of the hypoascorbemic guinea pig. Linus Pauling Institute of Science and
Medicine, Palo Alto, CA 94306-2025. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9388-90.
6 Stubbs P, Seed M, Moseley D, O'Connor
B, Collinson P, Noble M. A
prospective study of the role of lipoprotein(a) in the pathogenesis of unstable
angina. Charing Cross and Westminster Medical School, London, U.K. Eur
Heart
J. 1997 Apr;18(4):603-7.
7 Pauling L. Case Report: Lysine/Ascorbate-related
Amelioration
of Angina Pectoris. J Orthomolecular Med. 1991;6:144-46.
8 Griffith RS, Norins AL, Kagan
C. A
multicentered study of lysine therapy
in Herpes simplex infection. Dermatologica. 1978;156(5):257-67.
- Kagan, C. "Lysine Therapy for Herpes Simplex",
The Lancet, 1:137
26 Jan 1974
9 Thein DJ, Hurt WC. Lysine
as a prophylactic agent in the treatment of recurrent herpes simplex labialis.
Oral Surg Oral Med Oral Pathol. 1984 Dec;58(6):659-66.
10 Furst P. Dietary
L-Lysine supplementation; a promising nutritional tool in the prophylaxis and
treatment of osteoporosis. Nutrition. 1993 Jan-Feb;9(1):71-2.
11 Civitelli R, Villareal DT, Agnusdei
D, Nardi P, Avioli LV, Gennari C. Dietary
L-lysine and calcium metabolism in humans. Institute of Medical Pathology,
University
of Siena, Italy. Nutrition. 1992 Nov-Dec;8(6):400-5.
12 Flondin NW. The metabolic roles,
pharmacology, and toxicology of lysine. J Am Coll Nutr. 1997; 16:7-21.
13 Rajamohan T, Kurup PA. Lysine:
arginine ratio of a protein influences cholesterol metabolism. Part 1--Studies
on sesame protein having low lysine: arginine ratio. Department of Biochemistry,
University of Kerala Kariavattom, Thiruvananthapuram, India. Indian J Exp Biol.
1997 Nov;35(11):1218-23.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
|